Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/1996
07/09/1996US5534517 (Aryl(alkyl)carbonyl)-heterocyclic compounds and their use in the treatment of anxiety and depression
07/09/1996US5534515 Pyrrolopyridazines having gastrointestinal protective effects
07/09/1996US5534514 Antitumor agents or for treatment of leukemia using mixtures of xanthopterin and isoxanthopterin suspension of carrier
07/09/1996US5534513 Antitumor potentiator and antitumor composition
07/09/1996US5534511 Aminoalkyl benzoxazolinones and benzothiazolinones
07/09/1996US5534510 2-[1-(1,3-thiazolin-2-yl)azetidin-3-yl]thio-carbapenem derivatives
07/09/1996US5534509 Pharmaceutical composition regulating function of a living body
07/09/1996US5534508 Cephem compounds and antimicrobial agents
07/09/1996US5534506 Detecting or treating diseased tissue or body fluids, radiation
07/09/1996US5534505 Ursodeoxycholic acid-containing medicament in a liquid adminstration form
07/09/1996US5534503 2'-O, N6 -disubstituted and 2'-O, N6, 2-trisubstituted adenosines and their medicinal uses
07/09/1996US5534275 Foodstuffs containing a cereal ingredient and ferric EDTA
07/09/1996US5534268 Liposomes containing bioavailable iron (II) and process for obtaining them
07/09/1996US5534261 Retinoid-based compositions and method for preventing adhesion formation using the same
07/09/1996US5534253 Gentamycin
07/09/1996US5534250 Polymers containing diester units
07/09/1996US5534242 Hydrofluorocarbon propellant
07/09/1996US5533836 Compositions and methods for stimulating the growth of osteoblasts
07/09/1996CA2099381C Imidazopyridine paf/h _antagonists
07/09/1996CA2073601C Pharmaceutical compositions containing rifaximin for treatment of vaginal infections
07/09/1996CA2000666C Method of making a free-flowing, spray-dried edible powder comprising an oil
07/09/1996CA1338445C 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents
07/09/1996CA1338441C Expression of immunologically active proteins of human .beta.-lympho tropic virus
07/09/1996CA1338439C Controlled release formulations of tetracycline compounds
07/09/1996CA1338438C Pharmaceutical composition
07/06/1996CA2166527A1 Topical pharmaceutical compositions
07/05/1996CA2166427A1 Use of bile acids for preparing medicaments for the treatment of skin diseases
07/05/1996CA2166372A1 Pseudopeptides having a trifluoromethyl-substituted 2-azabicyclooctane
07/04/1996WO1996020281A1 Human phosphodiesterase type ivc, and its production and use
07/04/1996WO1996020280A1 Isolated polysialyl transferases, nucleic acid molecules coding therefor, methods of production and use
07/04/1996WO1996020279A1 Method and reagent for prevention, inhibition of progression and regression of vascular diseases
07/04/1996WO1996020209A2 14α,17α-C2-BRIDGED 19-NOR-PROGESTERONE DERIVATIVES
07/04/1996WO1996020200A1 6-[triazolyl[3-(trifluoromethyl)phenyl]methyl]-2-quinolinones and -quinolinethiones
07/04/1996WO1996020199A2 Diclavulanate salt with a diamino ether and process of preparation
07/04/1996WO1996020198A1 Production of cefotaxime and new sodium salts
07/04/1996WO1996020197A1 Spiroketal derivatives, compositions containing them and their use as therapeutic agents
07/04/1996WO1996020194A1 Novel quinuclidine derivatives and medicinal composition thereof
07/04/1996WO1996020193A1 Compounds and methods
07/04/1996WO1996020192A1 Piperidineacetic acid derivatives useful as fibrinogen antagonist agent
07/04/1996WO1996020190A1 Piperazine 2,5 dione derivatives as modulators of multi-drug resistance
07/04/1996WO1996020187A2 Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products
07/04/1996WO1996020184A1 Naphthyl-benzoxazepines or -benzothiazepines as squalene synthetase inhibitors
07/04/1996WO1996020180A1 Piperazine-2,5-dione derivatives as modulators of multidrug resistance
07/04/1996WO1996020176A1 Huperzine a derivatives, their preparation and their use
07/04/1996WO1996020175A1 1,4,4-(trisubstituted)cyclohex-1-ene derivatives as pde iv- and tnf-inhibitors
07/04/1996WO1996020174A1 1,3,3-(trisubstituted)cyclohexane monomers and related compounds
07/04/1996WO1996020173A1 Piperazine derivatives, medicaments containing the same, their use and process for preparing the same
07/04/1996WO1996020172A1 FIBRINOGEN RECEPTOR ANTAGONISTS HAVING SUBSTITUTED β-AMINO ACID RESIDUES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
07/04/1996WO1996020171A1 Antiherpes peptidomimetic compounds
07/04/1996WO1996020169A1 High purity n-(4-[n,n-bis(2-iodoethyl)amino]phenoscycarbonyl)-l-glutamic acid
07/04/1996WO1996020162A1 1,4,4-(trisubstituted)cyclohex-1-ene dimers and related compounds
07/04/1996WO1996020161A1 4,4-(disubstituted)cyclohexan-1-ol dimers and related compounds
07/04/1996WO1996020160A1 1,3,3-(trisubstituted)cyclohexane dimers and related compounds
07/04/1996WO1996020159A1 3,3-(disubstituted)cyclohexan-1-ylidine acetate monomers and related compounds
07/04/1996WO1996020158A1 3,3-(disubstituted)cyclohexan-1-one monomers and related compounds
07/04/1996WO1996020157A1 3,3-(disubstituted)cyclohexan-1-ol dimers and related compounds
07/04/1996WO1996020156A1 3,3-(disubstituted)cyclohexan-1-carboxylate dimers and related compounds
07/04/1996WO1996020153A1 4,4-(disubstituted)cyclohexan-1-one dimers and related compounds
07/04/1996WO1996020011A1 Chemical compounds
07/04/1996WO1996020009A1 Use of a tachykinin antagonist and an opioid analgesic
07/04/1996WO1996020000A1 Cosmetic or pharmaceutical and particularly dermatological composition, and culture medium containing a smelophyllum capense extract
07/04/1996WO1996019998A1 Bone mass anabolic composition comprising olpadronate
07/04/1996WO1996019997A1 Compounds with progesterone-antagonistic and anti-oestrogen properties intended for combined use in female contraception
07/04/1996WO1996019996A1 NEW USES OF INDOLO-[2,3b]-QUINOXALINES
07/04/1996WO1996019995A1 4,4-(disubstituted)cyclohexan-1-one monomers and related compounds
07/04/1996WO1996019994A1 3,3-(disubstituted)cyclohexan-1-carboxylate monomers and related compounds
07/04/1996WO1996019993A1 1,3,3-(trisubstituted)cyclohex-1-ene monomers and related compounds
07/04/1996WO1996019992A1 4,4-(disubstituted)cyclohexan-1-ylidine acetate monomers and related compounds
07/04/1996WO1996019991A1 Benzimidazoles as inhibitors of calcitriol metabolism
07/04/1996WO1996019990A1 4,4-(disubstituted)cyclohexan-1-carboxylate monomers and related compounds
07/04/1996WO1996019989A1 A composition containing pharmaceutically effective amount of thiadiazole compound for treatment of central nervous system tumor types
07/04/1996WO1996019988A1 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds
07/04/1996WO1996019987A1 Use of nebivolol as an anti-atherogenic
07/04/1996WO1996019986A1 1,4,4-(trisubstituted)cyclohexane monomers and related compounds
07/04/1996WO1996019985A1 3,3-(disubstituted)cyclohexan-1-ylidine acetate dimers and related compounds
07/04/1996WO1996019984A1 4,4-(disubstituted)cyclohexan-1-ylidine acetate dimers and related compounds
07/04/1996WO1996019983A1 4,4-(disubstituted)cyclohexan-1-ylidine acetate dimers and related compounds
07/04/1996WO1996019982A1 Processes of preparing pharmaceutical compositions containing ibuprofen
07/04/1996WO1996019981A1 A gelatine capsule containing selegiline or derivative and paraffin as carrier
07/04/1996WO1996019980A1 3,3-(disubstituted)cyclohexan-1-one dimers and related compounds
07/04/1996WO1996019979A1 1,4,4-(trisubstituted)cyclohexane dimers and related compounds
07/04/1996WO1996019978A1 1,3,3-(trisubstituted)cyclohex-1-ene dimers and related compounds
07/04/1996WO1996019977A1 3,3-(disubstituted)cyclohexan-1-ol monomers and related compounds
07/04/1996WO1996019975A1 Transdermal resorption of active substances from supercooled masses
07/04/1996WO1996019973A1 Processes of preparing pharmaceutical compositions
07/04/1996WO1996019972A1 Low rigidity liposomal antibacterial composition
07/04/1996WO1996019970A1 Hemolysis prevention by surfactants and emulsions
07/04/1996WO1996019969A1 Stable budesonide solutions, method of preparing them and use of these solutions as enema preparations and pharmaceutical foams
07/04/1996WO1996019968A1 Pharmaceutical aerosol containing at least one sugar
07/04/1996WO1996019956A1 Transdermal administration of apomorphine
07/04/1996WO1996013267A3 Combinations of prostaglandins and brimonidine or derivatives thereof for the treatment of glaucoma
07/04/1996WO1996003401A3 Process for the production of aminoazobicycloalkanes from oximes
07/04/1996DE4447599A1 Use of racemic or enantiomeric alpha liponic acid and derivs
07/04/1996DE4447401A1 14,17-C¶2¶-überbrückte Steroide 14,17-bridged C¶2¶-steroids
07/04/1996DE4447336A1 Ethereal oil mixt. contg. peppermint and eucalyptus oil
07/04/1996DE4446891A1 Stabile wäßrige Budesonid-Lösung Stable aqueous budesonide solution
07/04/1996DE19500027A1 Use of acid e.g. citric acid or esp. glutamic acid hydrochloride for treatment of hepatic encephalopathy
07/04/1996CA2208502A1 Method and reagent for prevention, inhibition of progression and regression of vascular diseases
07/04/1996CA2208501A1 3,3-(disubstituted)cyclohexan-1-one monomers and related compounds
07/04/1996CA2208456A1 4,4-(disubstituted)cyclohexan-1-one monomers and related compounds
1 ... 6901 6902 6903 6904 6905 6906 6907 6908 6909 6910 6911 6912 6913 6914 6915 6916 6917 6918 6919 6920 6921 ... 7860